IBD Patients Who Switch from Infliximab to Biosimilar See Mixed Results
Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis
Mirikizumab Promising for Plaque Psoriasis
Health Canada Approves Adalimumab for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients
FDA Approves Guselkumab Injector
Biosimilars: How Do They Affect Patient Care & Safety?
Why & How Our Biologic Drug Discussion with Patients Should Evolve
Biosimilar ABP 798 Promising for RA
FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients
- 1
- 2
- 3
- …
- 29
- Next Page »